Phathom Pharmaceuticals (PHAT) AI Analysis
Score
Phathom Pharmaceuticals is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 68/100) in Biotechnology. Under the hood: revenue compounding ~4109% annually over recent years. Street targets still imply ~172% upside.